Patient recruitment for cardiovascular clinical trials
Patient recruitment for cardiovascular clinical trials
Brining expertise to the heart of your patient recruitment
Our support of over 70 cardiovascular studies has made us experts in recruiting underrepresented groups in cardiovascular clinic. Whether you need a swift rescue or a strong start, we’ll help keep your recruitment on pace for success.
Whether you need a swift rescue or a strong start, we’ll help keep your recruitment on pace for success.
Overview of our experience in cardiovascular studies
75+
Cardiology studies supported, globally
10+
indications, including heart failure and hypertension
6
Regions where we’ve successfully randomized patients
Discover some of our areas of expertise
The global impact of cardiovascular disease
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, responsible for 17.9 million deaths annually – 31% of all global deaths. Over 612 million people live with CVDs, with most fatalities occurring in low and middle income countries.
Given their high prevalence and diverse nature, clinical trials are essential for advancing treatments.
How Clariness supports cardiovascular research
With 20 years of experience, Clariness has successfully supported over 75 cardiovascular disease (CVD) studies across six regions, covering all phases from Phase I to Phase IV.
We leverage a range of targeted channels to reach patients, using demographic categories such as age, gender, and risk factors, which we have identified through past experience and annual surveys. In addition, we utilize online forums, social media groups, and keywords that, while often indirectly related to heart disease, resonate with those affected by CVD.
Discover our successes in dermatology studies:
Ensuring women’s representation in cardiovascular clinical trials
Heart disease is the leading cause of death among women, yet they remain underrepresented in clinical trials. This disparity is due to various factors, including the complexities of studying women’s health across hormonal life cycles and other systemic barriers.
Women deserve equal representation in research to ensure they receive the best possible care.
Heart disease can present differently at every stage of a woman’s life, and certain types of heart attacks disproportionately affect women. Greater inclusion in clinical studies is essential for improving diagnosis, treatment and outcomes.
At Clariness, we are proud to have supported so many women in clinical trials. This past year, 62% of all participants in studies we’ve supported were women (significantly above the global average of 41%).
Whitepaper: Patient recruitment for cardiovascular disease clinical trials
Our whitepaper explores the key barriers preventing cardiovascular disease patients from participating in clinical trials and how organizers can address them.
It provides insights into recruitment challenges for conditions like peripheral arterial disease, heart failure, and stroke, along with effective, transferable solutions.
How can Clariness support my cardiovascular studies?
We have several options:
List your study on our global patient portal, ClinLife®
ClinLife® is a free platform that connects patients worldwide with clinical trials relevant to their medical conditions. Studies are organized by disease area or condition, allowing patients to easily find trials that match their needs.
Want to learn more about listing your study on ClinLife®?
List your study on ClinLife® and launch a tailored recruitment campaign
Maximize your study’s reach with a customized recruitment campaign. We’ll list your study across 40+ online channels and deliver geo-targeted ads to engage patients near your trial sites.
Interested in a strategy session to discuss how we can tailor a campaign for you?
Custom creatives tailored to promote your studies effectively
Our study creatives service offers a comprehensive suite of materials designed to effectively promote your study both online and offline. We specialize in creating:
1. A dedicated study website
2. Study flyers and posters
3. Visit reminder cards
4. Patient welcome guides
Some recent patient recruitment successes
Exceeded recruitment goals by 12%
We referred 12% more referrals than planned (over 8k+) in a Phase III cardiovascular disease study for a large pharmaceutical company. Over 5 months, we contributed 21% of randomized patients at the 250 sites we supported across 16 countries in LATAM, NA, EU and APAC.
Reached recruitment targets 2 months ahead of schedule
Our client came to us to rescue a behind-plan patient recruitment for a Phase III cardiovascular study program supporting 2 protocols. The campaign spanned 188 sites in 7 countries and ultimately reached our enrollment target 2 months ahead of schedule despite the difficult I/E criteria that caused many sites to discontinue the study.
Are you designing a cardiology study, or have one underway?
We can help you find the right patients, at the right time. To find out more, contact us.